ClinicalTrials.gov
ClinicalTrials.gov Menu

Left Ventricular Capture Management Study (LEARN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01089634
Recruitment Status : Completed
First Posted : March 18, 2010
Last Update Posted : April 26, 2018
Sponsor:
Information provided by (Responsible Party):
Medtronic Cardiac Rhythm and Heart Failure

Brief Summary:

Primary Objective:

To characterize left ventricular (LV) threshold behavior over time using daily left ventricular capture management (LVCM) measurements.

Study Design:

This is a multicenter, prospective, non-interventional study with patients receiving their first cardiac resynchronisation therapy-implantable cardioverter defibrillator (CRT-ICD) device. The study design, based on the primary objective, is an observational examination of LV thresholds over time. Daily left ventricular threshold measurements will be collected using the LVCM feature. Up to 150 patients will be enrolled in Canada to evaluate the primary objective at up to 15 study centers.

Data will be collected at Baseline, Implant, 12 months post-implant and all regularly scheduled follow-up visits up to 12 months post-implant.

Devices:

The ConcertoTM CRT-ICD device and future Medtronic CRT-ICD devices containing the LVCM feature will be used in this study.


Condition or disease
Ventricular Fibrillation Ventricular Tachycardia Bradyarrhythmia

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 151 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Left Ventricular Capture Management (LEARN) Study
Study Start Date : October 2007
Actual Primary Completion Date : November 2010
Actual Study Completion Date : December 2010






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
  • Patients who will be implanted with their first CRT defibrillator system.
  • Patients who will be implanted with a Medtronic CRT defibrillator containing the LVCM feature.
  • Patients who are willing and able to sign an IRB/MEC approved patient informed consent.
  • Patients who are geographically stable and available for follow-up at the study center for the required follow-up duration of the study
Criteria

Inclusion Criteria:

  • Patients who will be implanted with their first CRT defibrillator system.
  • Patients who will be implanted with a Medtronic CRT defibrillator containing the LVCM feature.
  • Patients who are willing and able to sign an IRB/MEC approved patient informed consent.
  • Patients who are geographically stable and available for follow-up at the study center for the required follow-up duration of the study

Exclusion Criteria:

  • Patients who have a pre-existing LV lead prior to enrollment
  • Patients who have a life expectancy of less than 1 year
  • Patients included in another clinical trial that will affect the objectives of this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01089634


Locations
Canada, Quebec
McGill University Health Center
Montreal, Quebec, Canada, H3G 1A4
Sponsors and Collaborators
Medtronic Cardiac Rhythm and Heart Failure
Investigators
Study Chair: Mary McCann, R.N., MBA Medtronic
Study Chair: Allison Rubino Medtronic

Responsible Party: Medtronic Cardiac Rhythm and Heart Failure
ClinicalTrials.gov Identifier: NCT01089634     History of Changes
Other Study ID Numbers: LEARN2007
First Posted: March 18, 2010    Key Record Dates
Last Update Posted: April 26, 2018
Last Verified: April 2018

Keywords provided by Medtronic Cardiac Rhythm and Heart Failure:
LV measurement
CRT
Concerto
LVCM
LV threshold
new CRT

Additional relevant MeSH terms:
Tachycardia
Tachycardia, Ventricular
Ventricular Fibrillation
Bradycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes